FIGURE 10. Estimated mean MSFC composite (a), T25-FW (b), 9-HPT (c) and PASAT (d) z-scores, with 95% CIs, at each visit, separated by treatment group.
FIGURE 10. Estimated mean MSFC composite (a), T25-FW (b), 9-HPT (c) and PASAT (d) z-scores, with 95% CIs, at each visit, separated by treatment group.
FIGURE 10. Estimated mean MSFC composite (a), T25-FW (b), 9-HPT (c) and PASAT (d) z-scores, with 95% CIs, at each visit, separated by treatment group.
FIGURE 10. Estimated mean MSFC composite (a), T25-FW (b), 9-HPT (c) and PASAT (d) z-scores, with 95% CIs, at each visit, separated by treatment group.

FIGURE 10

Estimated mean MSFC composite (a), T25-FW (b), 9-HPT (c) and PASAT (d) z-scores, with 95% CIs, at each visit, separated by treatment group. The numbers of patients with scores calculated at each visit, in each treatment group, are given directly above the CI for placebo and directly below the CI for active. Green points, active treatment; black points, placebo.

From: Chapter 3, Results: main study and magnetic resonance imaging substudy

Cover of The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Health Technology Assessment, No. 19.12.
Ball S, Vickery J, Hobart J, et al.
Southampton (UK): NIHR Journals Library; 2015 Feb.
Copyright © Queen’s Printer and Controller of HMSO 2015. This work was produced by Ball et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.